These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hepatitis C virus. Epidemiology, transmission and prevention. van der Poel CL Curr Stud Hematol Blood Transfus; 1994; (61):137-63. PubMed ID: 7956327 [No Abstract] [Full Text] [Related]
23. [Route of transmission and prevention of non-A, non-B hepatitis]. Iino S Nihon Rinsho; 1988 Dec; 46(12):2729-34. PubMed ID: 3149346 [No Abstract] [Full Text] [Related]
24. Transfusion-associated hepatitis C: reducing the risk. Gill P Transfus Med Rev; 1993 Apr; 7(2):104-11. PubMed ID: 8386960 [No Abstract] [Full Text] [Related]
25. Health care-associated transmission of hepatitis B and C in oncology care. Stevens MP; Edmond MB Clin Liver Dis; 2010 Feb; 14(1):69-74; viii. PubMed ID: 20123441 [TBL] [Abstract][Full Text] [Related]
26. [Hepatitis C and ALT in blood donors]. García Bueno MJ Sangre (Barc); 1991 Jun; 36(3):252-3. PubMed ID: 1948551 [No Abstract] [Full Text] [Related]
27. [Prevention of infection with hepatitis C virus in medical personnel as an aspect of risk management]. Arakawa Y; Tanaka N; Kaneko M; Arakawa Y; Moriyama M Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):297-312. PubMed ID: 15359810 [No Abstract] [Full Text] [Related]
28. Hepatitis C: who is at risk and how do we identify them? Goldberg D; Anderson E J Viral Hepat; 2004 Sep; 11 Suppl 1():12-8. PubMed ID: 15357858 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C, other types of non-B parenteral hepatitis and blood transfusion. Dodd RY Dev Biol Stand; 1993; 81():35-40. PubMed ID: 8174817 [TBL] [Abstract][Full Text] [Related]
30. [HIV/AIDS and hepatitis C transmission by blood transfusion: zero risk does not exist]. Rev Infirm; 2002 Apr; (80):11. PubMed ID: 12046116 [No Abstract] [Full Text] [Related]
31. Risk factors for the acquisition of hepatitis C. Bergk A; Berg T; Neumann UP Minerva Gastroenterol Dietol; 2005 Mar; 51(1):7-14. PubMed ID: 15756143 [TBL] [Abstract][Full Text] [Related]
32. Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis. Plunkett BA; Grobman WA Am J Obstet Gynecol; 2004 Sep; 191(3):998-1003. PubMed ID: 15467579 [TBL] [Abstract][Full Text] [Related]
35. Estimated risk of transmission of hepatitis C virus by blood transfusion. Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400 [TBL] [Abstract][Full Text] [Related]
36. Transfusion-transmitted diseases: current problems and challenges. Bove JR Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795 [No Abstract] [Full Text] [Related]
37. Hepatitis C virus and human T cell leukemia virus type 1 infection without [corrected] blood transfusion in hemodialysis units and its prevention. Washio M J Epidemiol; 1997 Sep; 7(3):183. PubMed ID: 9337517 [No Abstract] [Full Text] [Related]
38. Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years. Koltan S; Styczynski J; Wysocki M; Koltan A; Kurylak A; Debski R Haematologica; 2004 Feb; 89(2):251-2. PubMed ID: 15003909 [No Abstract] [Full Text] [Related]
39. Non-A, non-B hepatitis. Thomas HC Q J Med; 1987 Oct; 65(246):793-8. PubMed ID: 3130648 [No Abstract] [Full Text] [Related]
40. Hepatitis C virus infection in blood donors: to screen or not to screen? Anand AC; Dhot PS; Ohri VC Natl Med J India; 1997; 10(6):304-5. PubMed ID: 9481109 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]